Russell Amato headshot

Russel Amato

Senior Medical Science Liaison

Genomind

Dr. Russell Amato received his PhD in Pharmacology at Louisiana State University and has over a decade of experience in developing novel therapeutics for neuropsychiatric diseases including drug abuse, depression, anxiety and ADHD. His PhD work focused on the evaluation of neuroactive steroids in preclinical models of alcohol addiction, as well as assessing these compounds for their potential utility in cognitive disorders. He completed his postdoctoral fellowship within the Vanderbilt Center for Neuroscience Drug Discovery, where he evaluated metabotropic glutamate receptor negative allosteric modulators for the treatment of cocaine addiction, in addition to evaluating these compounds for use in depressive/anxiety disorders. Before coming to Genomind, Dr. Amato also worked on the development of antisense oligonucleotides as a novel therapy for genetic polymorphisms in a preclinical model of Usher Syndrome, providing him with a strong background in both genetics and psychiatric disease.

Advertizing
Advertizing

Other speakers in 2021

Ella Balasa

USA

Ella Balasa

Patient Advocate
Advocacy and Engagement Consultant
Kristina Russeva headshot

Bulgaria

Christina Rousseva

Clinician, Psychiatrist
Mental Health Clinic ‘St.st Cozma and Damian’, Plovdiv
Catherine Alix-Panabières headshot

France

Catherine Alix-Panabières, PhD Dr

Associate Professor at the Faculty of Medicine of the University of Montpellier
Director of the Laboratory Rare Circulating Human Cells (LCCRH) à l'Université et CHU de Montpellier
Skip to content